🇺🇸 FDA
Patent

US 7794714

Newcastle disease virus monoclonal antibodies

granted A61PA61P37/00

Quick answer

US patent 7794714 (Newcastle disease virus monoclonal antibodies) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P37/00